Biocompatibility testing to iso 10993 was successfully completed on skin-contacting surfaces of the lifevest device as well as the blue(tm) defibrillation gel.Electrode belt sn (b)(4) was returned and evaluated at the distributor in accordance with procedures recommended by zoll manufacturing corporation.The evaluation included download data review and incoming functional testing.During the incoming functional testing, the ecg acquisition and pulse delivery circuitry were verified.Upon evaluation, there was no evidence of a gel leak from any of the therapy electrode.
|
A us distributor reported that the patient had developed a red, itchy rash under the back therapy electrodes.The patient's nurse indicated that the belt was leaking gel from the right therapy electrode and suggested to use hydrocortisone cream on the rash.After using the cream, the patient's rash did not improved.The patient's physician suggested to use neosporin on the rash instead.Since using the neosporin, the patient's rash has improved.
|